Skip to main content

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued NOFO Number Activity Code Posting Date Expiration Date Opportunity Type
Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative A... NOT-TR-24-028 06/24/2024 Notice of Intent to Publish
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) PAR-24-158 R43/R44 02/28/2024 01/05/2027 NA
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed) PAR-24-157 R41/R42 02/28/2024 01/05/2027 NA
Addressing Health Inequities in Clinical Diagnostics (R41/R42 and R43/R44 Clinical Trials Not Allowed): Notice of Technical Webinar NOT-TR-24-026 05/23/2024 Notice of Information
Notice of Information: Technical Assistance Webinars for PAR-24-206: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical ... NOT-TR-24-024 05/01/2024 Notice of Information
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) PAR-24-131 R43/R44 04/25/2024 04/05/2027 NA
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) PAR-24-133 R41/R42 04/25/2024 04/05/2027 NA
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) PAR-24-197 R03 04/17/2024 07/16/2026 NA
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) PAR-24-206 U54 04/02/2024 08/13/2024 NA
Notice of Special Interest (NOSI): Translating Biomaterials-Based Technologies to Commercially Viable Products NOT-EB-24-001 R41/R42, R43/R44 03/29/2024 04/05/2027 Notice of Special Interest
Showing Row 1 to 10 of 374

Last updated on April 19, 2024